Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Boiron, Inc.
WARNING LETTER
•Boiron, Inc.•September 12, 2023

Boiron, Inc. – FDA Warning Letter, Sep 12, 2023

Record Details

On September 11, 2023, the FDA issued a Warning Letter to Boiron SA following a July 2023 review of their websites (boironusa.com, facebook.com/BoironUSA, instagram.com/boironusa/). The FDA found that Boiron SA offers "Optique 1 Eye Drops" for sale in the U.S., which is deemed an unapproved new drug under section 505(a) of the FD&C Act, 21 U.S.C. 355(a).

The product is considered a drug under section 201(g)(1) of the FD&C Act due to claims on their websites indicating intended use for diagnosis, cure, mitigation, treatment, or prevention of disease, and/or affecting body structure/function. Examples of claims include "EYE IRRITATION RELIEF," "Dry Eyes ● Allergies ● Eyestrain," and soothing red, dry, itchy, gritty, burning, or tired eyes from various irritants.

The FDA states that "Optique 1 Eye Drops" is not generally recognized as safe and effective (GRASE) for its claimed uses, making it a "new drug" under section 201(p) of the FD&C Act, 21 U.S.C. 321(p). Introducing or delivering this product into interstate commerce without an FDA

Company
Boiron, Inc.
Inspection date
September 12, 2023
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Jill P. Furman (Director)
View Company Profile

ID · 0d417bb4-64c3-414b-b6b6-642b25ad840b

Violation Codes4
21.U.S.C. 355(a)21 U.S.C. 331(d)21 U.S.C. 321(g)(1)21 U.S.C. 321(p)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Boiron, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.